Annual Total Expenses
$472.85 M
-$60.81 M-11.39%
December 31, 2023
Summary
- As of February 7, 2025, FOLD annual total expenses is $472.85 million, with the most recent change of -$60.81 million (-11.39%) on December 31, 2023.
- During the last 3 years, FOLD annual total expenses has fallen by -$31.89 million (-6.32%).
- FOLD annual total expenses is now -11.39% below its all-time high of $533.66 million, reached on December 31, 2022.
Performance
FOLD Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$116.72 M
+$5.01 M+4.49%
September 30, 2024
Summary
- As of February 7, 2025, FOLD quarterly total expenses is $116.72 million, with the most recent change of +$5.01 million (+4.49%) on September 30, 2024.
- Over the past year, FOLD quarterly total expenses has dropped by -$1.81 million (-1.53%).
- FOLD quarterly total expenses is now -33.49% below its all-time high of $175.48 million, reached on September 30, 2018.
Performance
FOLD Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
FOLD Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.4% | -1.5% |
| 3 y3 years | -6.3% | -1.5% |
| 5 y5 years | +13.5% | -1.5% |
FOLD Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.4% | at low | -23.5% | +4.5% |
| 5 y | 5-year | -11.4% | at low | -23.5% | +4.5% |
| alltime | all time | -11.4% | +7064.4% | -33.5% | +1040.7% |
Amicus Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $116.72 M(+4.5%) |
| Jun 2024 | - | $111.70 M(-15.4%) |
| Mar 2024 | - | $132.08 M(+11.2%) |
| Dec 2023 | $472.85 M(-11.4%) | $118.77 M(+0.2%) |
| Sep 2023 | - | $118.53 M(+5.9%) |
| Jun 2023 | - | $111.89 M(-9.5%) |
| Mar 2023 | - | $123.66 M(-4.0%) |
| Dec 2022 | $533.66 M(+5.6%) | $128.84 M(+12.1%) |
| Sep 2022 | - | $114.96 M(-18.6%) |
| Jun 2022 | - | $141.23 M(-5.0%) |
| Mar 2022 | - | $148.63 M(-2.6%) |
| Dec 2021 | $505.43 M(+0.1%) | $152.57 M(+28.6%) |
| Sep 2021 | - | $118.66 M(+3.0%) |
| Jun 2021 | - | $115.23 M(-3.2%) |
| Mar 2021 | - | $118.99 M(-11.8%) |
| Dec 2020 | $504.74 M(+4.5%) | $134.94 M(+13.2%) |
| Sep 2020 | - | $119.16 M(+5.5%) |
| Jun 2020 | - | $112.98 M(-17.9%) |
| Mar 2020 | - | $137.65 M(-4.2%) |
| Dec 2019 | $482.98 M(+15.9%) | $143.67 M(+36.5%) |
| Sep 2019 | - | $105.28 M(-12.3%) |
| Jun 2019 | - | $120.08 M(+5.4%) |
| Mar 2019 | - | $113.94 M(+12.2%) |
| Dec 2018 | $416.72 M(+68.2%) | $101.53 M(-42.1%) |
| Sep 2018 | - | $175.48 M(+158.3%) |
| Jun 2018 | - | $67.94 M(-5.3%) |
| Mar 2018 | - | $71.78 M(-8.1%) |
| Dec 2017 | $247.81 M(+37.7%) | $78.11 M(+20.3%) |
| Sep 2017 | - | $64.93 M(+22.1%) |
| Jun 2017 | - | $53.17 M(+3.0%) |
| Mar 2017 | - | $51.61 M(+1.8%) |
| Dec 2016 | $180.02 M(+42.8%) | $50.71 M(-0.9%) |
| Sep 2016 | - | $51.17 M(+33.4%) |
| Jun 2016 | - | $38.35 M(-3.6%) |
| Mar 2016 | - | $39.80 M(-1.5%) |
| Dec 2015 | $126.05 M | $40.39 M(+10.0%) |
| Sep 2015 | - | $36.74 M(+42.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $25.86 M(+12.2%) |
| Mar 2015 | - | $23.05 M(+7.3%) |
| Dec 2014 | $69.89 M(+11.7%) | $21.49 M(+21.4%) |
| Sep 2014 | - | $17.69 M(+17.0%) |
| Jun 2014 | - | $15.13 M(-2.9%) |
| Mar 2014 | - | $15.58 M(+10.3%) |
| Dec 2013 | $62.56 M(-12.3%) | $14.13 M(-6.9%) |
| Sep 2013 | - | $15.17 M(-5.2%) |
| Jun 2013 | - | $16.00 M(-7.2%) |
| Mar 2013 | - | $17.25 M(+8.3%) |
| Dec 2012 | $71.34 M(-1.4%) | $15.92 M(-5.9%) |
| Sep 2012 | - | $16.92 M(-15.4%) |
| Jun 2012 | - | $19.98 M(+7.9%) |
| Mar 2012 | - | $18.52 M(-0.8%) |
| Dec 2011 | $72.32 M(+27.4%) | $18.66 M(-1.4%) |
| Sep 2011 | - | $18.93 M(+0.9%) |
| Jun 2011 | - | $18.76 M(+17.5%) |
| Mar 2011 | - | $15.96 M(-8.6%) |
| Dec 2010 | $56.76 M(-19.1%) | $17.46 M(+31.6%) |
| Sep 2010 | - | $13.27 M(+4.6%) |
| Jun 2010 | - | $12.69 M(-5.0%) |
| Mar 2010 | - | $13.35 M(-11.1%) |
| Dec 2009 | $70.19 M(+19.1%) | $15.01 M(-18.4%) |
| Sep 2009 | - | $18.39 M(-4.3%) |
| Jun 2009 | - | $19.21 M(+9.3%) |
| Mar 2009 | - | $17.57 M(-8.6%) |
| Dec 2008 | $58.92 M(+23.8%) | $19.22 M(+48.4%) |
| Sep 2008 | - | $12.95 M(-9.4%) |
| Jun 2008 | - | $14.30 M(+14.9%) |
| Mar 2008 | - | $12.45 M(-18.5%) |
| Dec 2007 | $47.59 M(+1.6%) | $15.27 M(+29.3%) |
| Sep 2007 | - | $11.81 M(+14.8%) |
| Jun 2007 | - | $10.28 M(+0.5%) |
| Mar 2007 | - | $10.23 M |
| Dec 2006 | $46.86 M(+124.9%) | - |
| Dec 2005 | $20.83 M(+215.6%) | - |
| Dec 2003 | $6.60 M | - |
FAQ
- What is Amicus Therapeutics annual total expenses?
- What is the all time high annual total expenses for Amicus Therapeutics?
- What is Amicus Therapeutics annual total expenses year-on-year change?
- What is Amicus Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly total expenses year-on-year change?
What is Amicus Therapeutics annual total expenses?
The current annual total expenses of FOLD is $472.85 M
What is the all time high annual total expenses for Amicus Therapeutics?
Amicus Therapeutics all-time high annual total expenses is $533.66 M
What is Amicus Therapeutics annual total expenses year-on-year change?
Over the past year, FOLD annual total expenses has changed by -$60.81 M (-11.39%)
What is Amicus Therapeutics quarterly total expenses?
The current quarterly total expenses of FOLD is $116.72 M
What is the all time high quarterly total expenses for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly total expenses is $175.48 M
What is Amicus Therapeutics quarterly total expenses year-on-year change?
Over the past year, FOLD quarterly total expenses has changed by -$1.81 M (-1.53%)